Loading
If this is the first time anyone has visited this substance, we may be fetching live data from TGA Product Information, PBS, and state framework sources — that can take up to a minute. Cached substances load in a second or two.
“Dilart (valsartan) is an orally active, potent and specific angiotensin II (Ang II) receptor antagonist. It acts selectively on the AT 1 receptor subtype, which is responsible for the known actions of angiotensin II.”
“Valsartan shows bi-exponential decay kinetics with a t 1/2α of about 1h and a t 1/2β of about 9.5 hours.”
Working under the parallel aged-care framework? Aged-care equivalent →
Curated subset. The full adverse-effect list is in the TGA Product Information; click any citation above to open it.
“As valsartan is not metabolised to a significant extent, clinically relevant drug-drug interactions in the form of metabolic induction or inhibition of the cytochrome P450 system are not expected with valsartan.”